注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Effector Therapeutics Inc是一家臨床階段的生物製藥公司。該公司專注於開發選擇性翻譯調節劑抑製劑(STRIs)等腫瘤藥物。該公司使用選擇性翻譯調節技術平台在內部發現小分子STRI產品候選者的組合。該公司的候選產品針對eIF4F複合物及其激活激酶MNK。該公司的主要候選產品tomivosertib是MNK抑製劑,正在與KEYTRUDA(也稱為pembrolizumab)聯合進行評估。KEYTRUDA是在轉移性非小細胞肺癌(NSCLC)患者中進行的一項隨機IIb期臨床試驗中的程序性細胞死亡蛋白1(PD-1)抑製劑。該公司的第二個候選產品zotatifin是eIF4A(eIF4F複合物的組成部分)的抑製劑,正在某些實體瘤患者的I/II期臨床試驗進行評估。它的第三個項目專注於開發eIF4E抑製劑。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Ross L. Levine | 49 | - | Member of Scientific Advisory Board |
Barbara A. Kosacz | 62 | 2021 | Independent Director |
Elizabeth P. Bhatt | 53 | 2021 | Independent Director |
Christopher B. Ehrlich | 51 | 2020 | CEO & Director |
Caroline M. Loewy | 54 | 2021 | Independent Director |
Brian G. Atwood | 68 | 2021 | Independent Chairman of the Board |
Robert L. Garnick | 71 | - | Member of Scientific Advisory Board |
Adam Knight | - | - | Member of Scientific Advisory Board |
Rachel Wallach Humphrey | 60 | - | Member of Scientific Advisory Board |
Michael Dyszel | - | - | Member of Scientific Advisory Board |
Jeremy Goldberg | - | - | Chairman of Scientific Advisory Board |
Mike Hodges | - | - | Member of Scientific Advisory Board |
Stephen T. Worland | 64 | 2012 | CEO, President & Director |
Brian M. Gallagher | 52 | 2021 | Independent Chairman |
Jennifer A. Doudna | 59 | - | Member of Clinical & Scientific Advisory Board |
Joan S. Brugge | - | - | Member of Clinical & Scientific Advisory Board |
Kevan M. Shokat | - | - | Co-Founder and Member of Clinical & Scientific Advisory Board |
Barbara J. Klencke | 66 | 2021 | Independent Director |
Kristen Harrington-Smith | 50 | 2022 | Independent Director |
Neal Rosen | 73 | - | Member of Clinical & Scientific Advisory Board |
Davide Ruggero | - | - | Co-Founder and Member of Clinical & Scientific Advisory Board |
Kapil Dhingra | 64 | - | Member of Clinical & Scientific Advisory Board |
Robert J. Schneider | - | - | Member of Clinical & Scientific Advisory Board |
Sarat Chandarlapaty | - | 2023 | Member of Clinical & Scientific Advisory Board |
Funda Meric-Bernstam | - | - | Member of Clinical & Scientific Advisory Board |
Christopher B. Ehrlich | 53 | 2021 | Independent Director |
Elizabeth P. Bhatt | 55 | 2021 | Independent Director |
Caroline M. Loewy | 56 | 2023 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核